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Abstract
The lipoprotein receptor system in the hippocampus is intimately involved in the modulation of
synaptic transmission and plasticity. The association of specific apoE isoform expression with
human neurodegenerative disorders has focused attention on the role of these apoE isoforms in
lipoprotein receptor-dependent synaptic modulation. In the present study, we used the apoE2,
apoE3 and apoE4 targeted replacement (TR) mice along with recombinant human apoE isoforms
to determine the role of apoE isoforms in hippocampus area CA1 synaptic function. While synaptic
transmission is unaffected by apoE isoform, long-term potentiation (LTP) is significantly enhanced
in apoE4 TR mice versus apoE2 TR mice. ApoE isoform-dependent differences in LTP induction
require NMDA-receptor function, and apoE isoform expression alters activation of both ERK and
JNK signal transduction. Acute application of specific apoE isoforms also alters LTP induction while
decreasing NMDA-receptor mediated field potentials. Furthermore, acute apoE isoform
application does not have the same effects on ERK and JNK activation. These findings demonstrate
specific, isoform-dependent effects of human apoE isoforms on adult hippocampus synaptic
plasticity and highlight mechanistic differences between chronic apoE isoform expression and acute
apoE isoform exposure.
Introduction
More than a decade ago, the allelic variation of apolipo-
protein E (apoE) was associated with an altered risk of
Alzheimer's disease (AD) development [1,2]. The human
population maintains three commonly occurring apoE
isoforms that differ at two amino acid positions: apoE2
(Cys112, Cys158), apoE3 (Cys112, Arg158), and apoE4
(Arg112, Arg158). The apoE3 allele is maintained at an
allele frequency of approximately 78% in populations of
European descent and is described as having no effect on
AD risk. ApoE4, with an allele frequency of 14% in these
populations, is linked to an increased risk of developing
sporadic AD as well as a decreased age of onset compared
to inherited apoE3. In contrast, apoE2 expression
decreases disease risk compared to apoE3 [1,3].
In the CNS, apoE binds to the seven identified mamma-
lian members of the highly conserved low-density lipo-
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protein receptor (LDLR) family [4]. Research in the last
decade has established that the LDLR family is intimately
involved in neuronal signal transduction, modulation of
ligand-gated ion channels, and control of neurite out-
growth, synapse formation and neuronal migration (for
review see [5]). Of particular interest is the association of
apoE with two highly expressed members of the LDLR
family: apolipoprotein E receptor 2 (apoER2) and the very
low density lipoprotein receptor (VLDLR). Through the
experimental use of reelin, an apoER2 and VLDLR ligand,
these receptors have been linked to several signal trans-
duction pathways that play a role in synaptic maturation
and NMDA receptor modulation in the adult hippocam-
pus. Furthermore, disruption of reelin binding or apoER2
and VLDLR function through deletion or mutation results
in learning and memory defects [6-10]. While apoE also
associates with these important signaling receptors, rela-
tively little is known about apoE signaling in the CNS in
general, or how apoE isoforms may specifically affect syn-
aptic function.
The targeted replacement apoE isoform-expressing mice
(apoE TR) are a valuable tool for understanding the role
of apoE in memory formation and synaptic function.
These mice express one of the three human apoE isoforms
under the control of the endogenous murine promoter
[11]. The high degree of conservation between murine
and human apoE receptors allows for these mice to be
used as a general mammalian model for direct compari-
son of the actions of apoE isoforms [12,13]. Previous
work has shown that apoE4 TR mice have impaired spatial
memory retention during tests that apoE3 TR, apoE-defi-
cient, and murine apoE-expressing animals were able to
perform [14]. Studies of the electrophysiologic response
to hippocampal perforant path stimulation revealed tha
LTP induction in apoE3 TR mice was equivalent to the
wild-type controls, but both apoE2 TR and apoE-deficient
animals show significant reduction in LTP induction with
further reduction observed in apoE4 TR mice [15]. An
investigation of a similar line of apoE targeted replace-
ment mice reveals an age-dependent enhancement of CA1
LTP in young apoE4 TR animals compared to wild-type
controls [16]. While these data suggest that the actions of
apoE isoforms can alter synaptic plasticity, an in-depth
study of hippocampus area CA1 synaptic function using
all of the available apoE TR mice is unfortunately absent.
Work from our group and others suggest that apoE has
similar signaling capabilities as the extracellular matrix
protein reelin and can modulate synaptic function in an
isoform-dependent manner. The present study deter-
mines apoE necessity and isoform-dependent changes of
synaptic transmission and plasticity in area CA1 of the
adult hippocampus in apoE TR mice. We reveal differ-
ences in the effects of apoE-isoforms under chronic or
acute exposure conditions and also explore the possible
mechanisms of hippocampal apoE isoform-dependent
signaling using both electrophysiological and biochemi-
cal techniques.
Results
LTP induction in apoE TR animals is isoform-dependent
The extracellular matrix protein reelin signals through
both apoER2 and VLDLR; these receptors also bind apoE.
However, unlike reelin-deficient mice, apoE TR and apoE-
deficient animals develop normally without gross patho-
logical changes to brain organization suggesting that apoE
signaling or apoE isoform expression are not involved in
neuronal migration during development. This has clear
advantages when examining parameters of synaptic func-
tion in apoE TR and apoE deficient mice. We find that hip-
pocampal slices from 3–5 month-old animals are
equivalent across genotypes and are identical to wild-type
hippocampi on a gross anatomical level.
Supporting the lack of structural changes, hippocampus
area CA1 synaptic transmission does not vary significantly
with apoE isoform expression (figure 1A). These data
ensure an important parameter in plasticity studies: that
specific electrical 'input' elicits an equivalent synaptic
response 'output' regardless of genotype. Thus, subse-
quent variation in measured plasticity can be attributed to
apoE isoform rather than changes in CA1 synaptic con-
nectivity. Determination of short-term plasticity using
paired-pulse facilitation revealed typical percent facilita-
tion between apoE TR, apoE-deficient and wild-type mice
(C57BL/6J) (figure 1B).
High frequency stimulation of Schaeffer collateral syn-
apses using a standard theta burst stimulation protocol
induces robust potentiation [17,18]. Using five trains of
theta burst stimulation, we successfully induced potentia-
tion in wild-type, apoE-deficient, and apoE TR mice. The
magnitude of potentiation, however, was dramatically
different between apoE isoforms (figure 1C). Immediately
following stimulation and persisting for the duration of
the experiment, apoE4 TR mice had increased LTP induc-
tion (figure 1C). Potentiation in apoE4 TR mice was sig-
nificantly increased from that seen in the apoE2 TR (figure
1D; ANOVA, p = 0.0198). LTP induction in the apoE-defi-
cient mice was intermediate between apoE2 TR and apoE4
TR, but this trend was not significant. There was no signif-
icant difference in the magnitude of LTP induction
between wild-type and apoE-deficient animals. Interest-
ingly, the increased CA1 LTP in the apoE4 TR is contradic-
tory to perforant path LTP in the same animals [15,19],
suggesting a differential role for apoE in perforant path
and CA1 plasticity.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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ApoE4 TR animals show increased LTP induction without changes in synaptic transmission Figure 1
ApoE4 TR animals show increased LTP induction without changes in synaptic transmission. A) Input-output 
curve generated from the slope fEPSP versus fiber volley amplitude measured at increasing stimulus intensities. B) Paired pulse 
facilitation. Second stimuli delivered at 20 ms intervals from 20 to 300 ms from first stimuli. Percent facilitation of fEPSP slope 
of second response as percentage of first response. C) Long-term potentation induced by 5 trains of theta-burst stimulation 
(arrow). Expressed as slope of fEPSP, standardized to the first 20 minutes of recording. Representative traces 5 minutes before 
(black lines) and 40 minutes after (colored lines) stimulation for apoE4 (red) and apoE2 TR (blue). Scale: 0.5 mV, 2 ms. D) 
Average potentiation of last 20 minutes of recording. C57BL/6J = WT, green diamond, n = 12; apoE-deficient = E0, Black circle, 
n = 12; apoE2 TR = E2, blue square, n = 17; apoE3 TR = E3, purple inverted triangle, n = 6; apoE4 TR = E4, red triangle, n = 14. 
Data expressed as mean ± SEM. *p < 0.05, ANOVA with Bonferroni's posttest.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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We hypothesize that apoE isoforms differentially act as
ligands to a set of lipoprotein receptors that have the abil-
ity to modulate synaptic activity. However, the changes in
the amount of plasticity between specific apoE isoforms
may be due to intrinsic properties of the apoE TR mouse
or the production of compensatory protein expression
during chronic apoE isoform expression. To test for iso-
form-dependent signaling differences that could account
for our electrophysiology results in the TR mice, we pre-
pared hippocampal slices from apoE-deficient mice and
perfused with 100 nM of human recombinant E2, E3 and
E4 (rhapoE) prior to theta burst stimulation. ApoE-defi-
cient mice were chosen to insure that the presence of
endogenous murine apoE did not interfere with the
applied rhapoE. Perfusion of rhapoE2, rhapoE3 or
rhapoE4 has no effect on overall baseline synaptic trans-
mission (data not shown) or short-term plasticity (figure
2A). However, there is an isoform-dependent change in
synaptic plasticity following theta burst stimulation (fig-
ure 2B,C). Interestingly, the change in plasticity with spe-
cific isoform perfusion follows a trend similar to that
measured in the corresponding apoE isoform TR mouse;
both apoE4 TR animals and slices treated with rhapoE4
demonstrate significantly increased LTP induction over
apoE2 TR mice or treatment with rhapoE2, respectively
(rhapoE: ANOVA, p = 0.0112). This suggests that differ-
ences in synaptic plasticity are not developmentally-
dependent and that apoE acts as an isoform-specific sign-
aling molecule in the adult hippocampus.
Effect of apoE isoform on LTP is NMDAR dependent
The NMDA receptor is intimately associated with many
forms of synaptic plasticity and long-term potentiation,
including theta-burst-induced LTP [18,20]. In addition,
signal transduction via apoE receptors is linked to NMDA
receptor maturation [21,22], increased NMDA receptor
currents [23], and activation of signaling pathways that
involve NMDA receptor function [9,23,24]. These results
lead us to hypothesize that the observed alterations in LTP
may be due to apoE isoform-specific changes in NMDA
receptor function. Thus, we induced NMDA-receptor
independent LTP by delivering two one-second trains of
200 Hz stimulation concurrent with application of the
NMDA receptor antagonist APV (100 μM). Long-lasting
potentiation was induced in wild-type, apoE-deficient,
and apoE TR animals; however, we eliminated apoE iso-
form-dependent alterations of LTP induction (figure 3A–
B).
The normalization of NMDAR-independent LTP induc-
tion suggests that NMDARs are being modified by both
the presence of specific apoE isoforms in the TR mice and
by exogenous application of apoE isoforms. This can
occur through direct changes in NMDAR function indi-
cated by changes in phosphorylation and subsequent
modulation of NMDAR conductance. We took advantage
of the acute apoE-isoform application strategy to investi-
gate the ability of apoE isoforms to change CA1 NMDA
receptor function over time.
NMDA receptor field potentials were isolated by applica-
tion of 20 μM of the AMPA receptor antagonist CNQX fol-
lowed by application of 100 nM of rhapoE2, rhapoE3 or
rhapoE4. While we hypothesized that the enhanced LTP
seen in the presence of apoE4 was related to increased
NMDA receptor currents similar to the effect of reelin
application, we found that application of either rhapoE2
or rhapoE4 significantly reduced NMDA field potentials
from control levels (figure 4A–B). Interestingly, there was
no effect on NMDAR field potentials with the application
of rhapoE3. Although these results suggest a specific
change to NMDA receptors, there is also the possibility
that apoE isoforms can alter apoE receptors known to
influence NMDA receptors in the hippocampus, such as
apoER2.
ApoE isoforms do not alter apoER2 expression levels
Alterations in apoER2 expression and decreased reelin
expression can adversely affect spatial memory [9,25].
Furthermore, changes in reelin concentration and expres-
sion can alter LTP strength and induction as well as
NMDAR conductance [21,23]. This suggests that differ-
ences in receptor expression and concentration as well as
changes to lipoprotein receptor ligands may affect synap-
tic transmission or learning and memory. Therefore, we
probed for changes in overall expression levels of the
main apoE receptor in the brain, apoER2. Isolated hippoc-
ampus tissue was probed for apoER2 expression using
western blot analysis. Figure 5A indicates that apoE2,
apoE3 and apoE4-expressing animals exhibit no altera-
tions in total apoER2 expression in the hippocampus
(ANOVA, p = 0.8269); apoE deficient and murine apoE-
expressing animals are also equivalent in receptor expres-
sion (t-test, p = 0.6175). Recent studies by Riddell et al.
[26] suggest a differential apoE isoform expression in
whole hippocampus or frontal cortex homogenates. How-
ever, our results obtained with slightly different condi-
tions show that targeted replacement did not alter overall
apoE expression levels in the hippocampus (figure 5B,
ANOVA, p = 0.6912).
Role of apoE isoform in NMDAR phosphorylation
Tyrosine phosphorylation of NMDA-receptor subunits
has been shown to influence NMDA receptor trafficking
and assembly [27,28]. This tyrosine phosphorylation,
mediated by Src-family kinases such as Fyn, plays an inte-
gral role in hippocampal synaptic plasticity and LTP
[29,30]. With the identification of reduced NMDA recep-
tor-dependent field potentials with rhapoE2 and
rhapoE4, we hypothesized that apoE may be altering theMolecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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Acute recombinant apoE isoform application recapitulates alterations in LTP induction Figure 2
Acute recombinant apoE isoform application recapitulates alterations in LTP induction. Application of 100 nM 
recombinant human apoE isoforms 5 min prior to start of recording. A) Paired pulse facilitation. Second stimuli delivered at 20 
ms intervals from 20 to 300 ms from first stimuli. Percent facilitation of fEPSP slope of second response as percentage of first 
response. B) Long-term potentiation induced by 5 trains of theta-burst stimulation (arrow). Expressed as slope of fEPSP, stand-
ardized to the first 20 minutes of recording. C) Average potentiation of last 20 minutes of recording. control = black circle, n 
= 8; rhapoE2 = blue square n = 8; rhapoE3 = purple inverted triangle, n = 7; rhapoE4 = red triangle, n = 6. Data expressed as 
mean ± SEM. *p < 0.05, ANOVA with Bonferroni's posttest.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
Page 6 of 18
(page number not for citation purposes)
NMDA receptor-independent LTP is not affected by apoE isoform Figure 3
NMDA receptor-independent LTP is not affected by apoE isoform. A) Long term potentiation induced by 2 trains of 
200 Hz stimulation (arrow). Application of 100 μM APV for 5 minutes before and 20 minutes after 200 Hz stimulation. 
Expressed as slope of fEPSP, standardized to the first 20 minutes of recording. B) Average potentiation of last 20 minutes of 
recording. C57BL/6J = WT, green diamond, n = 5; apoE-deficient = E0, black circle n = 8; apoE2 TR = E2, blue square, n = 8; 
apoE3 TR = E3, purple inverted triangle, n = 7; apoE4 TR = E4, red triangle, n = 6. Data expressed as mean ± SEM.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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ApoE isoforms alter NMDA receptor-dependent field potentials Figure 4
ApoE isoforms alter NMDA receptor-dependent field potentials. A) Synaptic transmission in the presence of 20 μM 
CNQX (dashed line) and 100 nM human apoE (solid line). Expressed as slope of fEPSP, standardized to the first 20 minutes of 
recording. B) Average potentiation of last 20 minutes of recording. control = black circle, n = 8; rhapoE2 = blue square, n = 8; 
rhapoE3 = purple inverted triangle, n = 7; rhapoE4 = red triangle, n = 6. Data expressed as mean ± SEM. *p < 0.05, **p < 0.01, 
ANOVA with Bonferroni's posttest.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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ApoE isoform expression does not affect apoER2 expression levels Figure 5
ApoE isoform expression does not affect apoER2 expression levels. Representative western blots showing levels of 
apoE (A) and apoER2 (B) immunoreactivity in whole hippocampus of aged animals. Quantification of immunoreactivity stand-
ardized to actin (n = 8, n = 5 for apoE3 TR). C57BL/6J (WT, white), apoE-deficient (E0, light grey), apoE2 TR (E2, medium 
grey), apoE3 TR (E3, dark grey), apoE4 TR (E4, black). Data expressed as mean ± SEM.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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state of NMDA-receptor subunit tyrosine phosphoryla-
tion.
To test this possibility, we first attempted to immunopre-
cipitate NR2A and NR2B from hippocampus area CA1
samples from apoE TR animals. We found that there were
significant difficulties in our ability to immunoprecipitate
equivalent amounts either NR2A or NR2B from the differ-
ent apoE TR animals (data not shown). While this indi-
cates that there may be structural differences or
unidentified protein interactions with NMDA receptors
that prevent complete immunoprecipitation due to the
presence of apoE isoforms, it also hindered our ability to
determine potential isoform-specific modulation of
NR2A and NR2B phosphorylation. Therefore, we chose to
probe for NR1, NR2A and NR2B in homogenates of hip-
pocampus area CA1. We found that there were no signifi-
cant differences in total NR2A or NR2B levels,
standardized to NR1, between apoE2, apoE3 and apoE4
TR animals (figure 6A, B). We also probed for total tyro-
sine phosphorylation at the corresponding to NR2A and
NR2B protein band. Tyrosine phosphorylation at this
molecular weight was also unchanged between apoE TR
animals (figure 6C).
We were able to immunoprecipitate NR2A and NR2B
from area CA1 of the hippocampus that had been treated
with rhapoE isoforms. ApoE-deficient hippocampus slices
were isolated and incubated with 100 nM recombinant
apoE for 40 minutes before flash freezing on dry ice and
rapidly dissecting out CA1. We found that there were no
significant differences in the ratio of pNR2A to NR2A
between any of the conditions, but there was a trend
towards a reduced ratio in the rhapoE3 and rhapoE4
treated groups (figure 7A). Similarly, there were no signif-
icant differences in pNR2B to NR2B ratios (figure 7B).
ApoE isoform alters signal transduction
ApoE has been previously shown in neuronal cell culture
to have isoform specific effects on signal transduction
pathways crucial to synaptic plasticity such as ERK and
JNK [31]. As those effects were blocked with LDL receptor
inhibitors and the NMDA receptor antagonist MK-801, we
hypothesized that similar mechanisms may be underlying
the isoform-specific alterations in CA1 LTP.
Area CA1 dissected from acute hippocampal slices of apoE
TR, wild-type, and apoE-deficient animals were homoge-
nized and subjected to SDS-PAGE analysis. Membranes
were probed for pERK1/2, ERK1/2, pJNK1/2 or JNK1/2.
This revealed that pERK1/2 was significantly increased in
apoE4 TR animals versus apoE2 TR or apoE3 TR (figure
8Ai, ANOVA p = 0.0005). There were no accompanying
significant changes in total ERK (figure 8Aii). The ratio of
pERK to total ERK showed a significant increase in the
Effect of chronic apoE isoform expression on NR2A, NR2B levels and tyrosine phosphorylation Figure 6
Effect of chronic apoE isoform expression on NR2A, NR2B levels and tyrosine phosphorylation. A) Levels of 
NR2A immunoreactivity, standardized to NR1 immunoreactivity, from CA1 of apoE TR animals. B) Levels of NR2B immunore-
activity, standardized to NR1 immunoreactivity, from CA1 of apoE TR animals. C) Levels of phosphotyrosine immunoreactivity 
at the molecular weight corresponding to NR2A and NR2B from CA1 of apoE TR animals. apoE2 TR (E2, medium grey), apoE3 
TR (E3, dark grey), apoE4 TR (E4, black). Data expressed as mean ± SEM.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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Effect of acute apoE exposure on NR2A and NR2B tyrosine phosphorylation Figure 7
Effect of acute apoE exposure on NR2A and NR2B tyrosine phosphorylation. ApoE-deficient slices treated with 100 
nM rhapoE isoforms. A) Ratio of pNR2A as measured by pTyr immunoreactivity to NR2A immunoreactivity as immunopreci-
patated by NR2A. B) Ratio of pNR2B as measured by pTyr immunoreactivity to NR2B immunoreactivity as immunopreci-
patated by NR2B. control (C, light grey), rhapoE2 (E2, medium grey), rhapoE3 (E3, dark grey), rhapoE4 (E4, black). Data 
expressed as mean ± SEM.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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Chronic apoE isoform expression alters activation of ERK1/2 and JNK1/2 Figure 8
Chronic apoE isoform expression alters activation of ERK1/2 and JNK1/2. A) Quantification of levels of pERK (i) or 
ERK (ii) immunoreactivity in CA1 of apoE TR, wild-type, and apoE deficient animals. iii) pERK/ERK ratio. B) Quantification of 
levels of pJNK (i) or JNK (ii) immunoreactivity in CA1 of apoE TR, wild-type, or apoE deficient animals. iii) pJNK/JNK ratio. 
Quantification of immunoreactivity normalized to background (n = 5). C57BL/6J (WT, white), apoE-deficient (E0, light grey), 
apoE2 TR (E2, medium grey), apoE3 TR (E3, dark grey), apoE4 TR (E4, black). Data expressed as mean ± SEM. *p < 0.05, 
ANOVA with Bonferroni's posttest.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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apoE4 TR over apoE2 TR and apoE3 TR (figure 8Aiii,
ANOVA p = 0.003).
When pJNK levels were analyzed, we found a significant
reduction in apoE-deficient, versus wild-type animals (fig-
ure 8Bi, t-test p = 0.0003) and apoE2 and apoE3 TR versus
apoE4 TR animals (figure 8Bi, ANOVA p = 0.0075). This
was not accompanied by any significant changes in total
JNK. The pJNK/JNK ratio revealed a significant reduction
in apoE-deficient from wild-type (figure 8Bii, t-test
0.0015), and apoE2 TR and apoE3 TR animals from
apoE4 TR (figure 8Biii, ANOVA p = 0.0025).
In light of the differences in specific signal transduction
proteins in the apoE TR mice, we wanted to test the effects
of acute apoE exposure on signal transduction. ApoE-defi-
cient hippocampus slices were isolated and incubated
with 100 nM recombinant apoE for 40 minutes before
flash freezing on dry ice and rapidly dissecting out CA1.
Tissue samples were probed by western analysis for pERK,
pJNK, ERK and JNK. Unlike comparable apoE TR mice,
apoE isoform application did not significantly alter total
pERK levels (data not shown). There were no significant
differences in the pERK/ERK ratio (figure 9A). Further-
more, in contrast to what was seen with chronic apoE iso-
form expression, acute apoE isoform application did not
significantly alter either JNK or pJNK levels (data not
shown) or pJNK/JNK ratio (figure 9B). Taken together,
these data suggest that the effects on signal transduction
pathways and the potential compensatory changes of pro-
longed apoE isoform expression result in similar electro-
physiology results, but may be more representative of
different mechanisms underlying those physiologic
effects.
Discussion
Essential to defining how apoE influences the memory
disruption and etiology of neurodegenerative disorders
such as Alzheimer's disease is the establishment of the
role of apoE in synaptic function. However, the physio-
logic actions of apoE as a signaling molecule in the adult
CNS are unclear. In the present study we investigated both
the necessity for murine apoE expression in adult hippoc-
ampus area CA1 synaptic plasticity as well as potential dif-
ferences due to specific human apoE isoform expression.
We found a lack of an overt physiologic defect in apoE-
deficient animals with a C57Bl/6J background. This lack
of phenotype was especially valuable in comparing differ-
ences with specific isoform expression in apoE TR mice.
The apoE TR mice are particularly useful for these investi-
gations as they allow for the direct in vivo comparison of
the effects of apoE isoforms and reduce the potential cave-
ats associated with apoE isoform over-expression. Impor-
tantly, in the absence of other genetic manipulations
commonly used in mouse models of AD, these animals
do not develop the potentially confounding pathological
abnormalities know to affect memory formation and syn-
aptic plasticity. Moreover, we were able to utilize the lack
of a strong physiologic phenotype in apoE-deficient mice
in conjunction with acute application of human recom-
binant apoE isoforms to preclude the potential confound-
ing results of interactions or competition with
endogenous murine apoE.
Previous electrophysiological studies of apoE TR mice
have revealed that both perforant path LTP induction and
the vulnerability of this potentiation by oligomeric beta
amyloid (Aβ) vary with apoE isoform expression [15,19].
These studies show a decrease in LTP induction in apoE-
deficient, apoE2 TR and apoE4 TR animals, with the great-
est decrease in potentiation observed in apoE4 TR [15].
Our current study focuses on the well-characterized Schaf-
fer collateral synapses, as does the previous work on reelin
and its effects through the lipoprotein receptors apoER2
and VLDLR [9]. Although we predicted that the LTP induc-
tion profile would mirror that in the dentate gyrus, it was
surprising to see that apoE4 TR mice demonstrated selec-
tive enhancement of CA1 LTP and apoE2 TR mice show
the least amount of LTP induction.
ApoE isoforms acting as signaling ligands can change hip-
pocampal physiology and alter LTP induction in a
number of ways. One possibility is alteration of NMDA
receptors through changes in subunit composition and/or
phosphorylation. This possibility is already established as
an action of reelin through apoER2 and VLDLR
[21,22,32,33]. Our attempts to monitor changes in
NMDAR subunit composition and phosphorylation
through immunoprecipation revealed differences in our
ability to pull down either NR2A or NR2B consistently
between the apoE TR mice. Interestingly, total NR1 levels
in these assays did not vary with NR2A or NR2B levels. We
hypothesize that our ability to immunoprecipitate NR2A
and NR2B is being hindered by differential treatment of
NMDA receptors within neurons due to apoE signaling
and our experimental conditions are not accurately con-
trolling for these differences.
For the current study, we looked at total tyrosine phos-
phorylation corresponding to NR2A and NR2B in hippoc-
ampus area CA1 samples from apoE TR animals. We did
not find any differences in total levels of NR2A, NR2B, or
NR1 between groups; total tyrosine phosphorylation cor-
responding to NR2A and NR2B was also unchanged.
These results indicate that within the total denatured hip-
pocampal tissue our ability to detect NMDAR subunits are
unhindered and no significant exists with the presence of
specific apoE isoforms. However, it is difficult to discern
whether specific changes in signal transduction pathways
underlie the differences in LTP induction, or if there areMolecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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Effects of acute apoE isoform exposure on ERK1/2 and JNK1/2 activation Figure 9
Effects of acute apoE isoform exposure on ERK1/2 and JNK1/2 activation. Quantification of A) pERK/ERK rato and 
B) pJNK/JNK ratio in CA1 of apoE-deficient animals treated with 100 nM rhapoE isoforms (n = 6 for each). Representative 
western blots showing levels of pERK, ERK, pJNK, JNK, and actin. control (C, light grey), rhapoE2 (E2, medium grey), rhapoE3 
(E3, dark grey), rhapoE4 (E4, black). Data expressed as mean ± SEM.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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chronic changes in signaling resulting in slight alterations
to NMDAR subunit composition, localization or function
that may cumulatively exert a physiologic effect on LTP.
As shown by figure 10, it is likely that alterations in signal
transduction via apoER2 that impact NMDA receptor
function plus alterations in other signal transduction cas-
cades combine to produce apoE isoform-specific changes
in synaptic plasticity. Ongoing research in our laboratory
is investigating these potential possibilities.
The changes in LTP induction with acute apoE isoform
application are more difficult to explain. In this instance
changes in NMDAR subunit composition are unlikely,
and there were no significant changes in the ERK or JNK
signal transduction pathways. Interestingly, rhapoE4 did
not increase isolated NMDA receptor field potentials as
expected, but rather caused a significant decrease. Yet
there were no significant differences in the pNR2A/NR2A
or pNR2B/NR2B ratios with treatment of any rhapoE iso-
form. While the observed trend towards decreased NR2A
and NR2B phosphorylation with rhapoE4 treatment may
actually contribute to the apoE-induced decreases in
NMDAR field potentials, further studies will be necessary
to determine if there are other mechanisms such as desen-
sitization or internalization of NMDARs at work. Another
possibility is that application of a bolus of apoE isoform
Model of chronic apoE signaling in adult hippocampus Figure 10
Model of chronic apoE signaling in adult hippocampus. Reelin interacts exclusively with the lipoprotein receptors 
apoER2 and VLDLR, with a much higher affinity for apoER2. ApoE binds to all lipoprotein receptors and undergoes endocyto-
sis. Chronic apoE4 exposure enhances ERK1/2 activation, likely through interactions with the LRP1 receptor. In contrast, 
chronic apoE2 and apoE3 expression reduce activation of JNK1/2 and ERK1/2 activation. Together with proper NMDAR func-
tion, these changes culminate in alterations in LTP induction with chronic apoE2 isoform expression.Molecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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selectively blocks lipoprotein receptor activity. This situa-
tion occurs with an antibody that binds to the reelin asso-
ciation site of apoER2 (CR-50), which results in a decrease
in NMDA receptor whole cell currents [34]. Thus, the
decrease in NMDA receptor currents with rhapoE2 and
rhapoE4 may reflect an isoform-specific affinity for
apoER2 when using non-cholesterol associated human
recombinant protein. However, the ability for rhapoE4 to
increase LTP induction despite these decreases in NMDAR
field potentials suggests that apoE isoforms may also be
acting differentially as signaling molecules to alter other
components of the LTP machinery.
The idea of apoE as a signaling molecule is not new. In pri-
mary neuronal cell culture, application of either full
length apoE or a tandem repeat peptide of the receptor
binding domain of apoE significantly enhances phospho-
rylation of ERK1/2 and Dab-1 [32]. This pathway is well
validated as essential to the underlying mechanisms of
LTP [35,36], as well as learning and memory [37-39].
Modulation of these pathways by either pharmacological
or genetic manipulation has dramatic effects on both syn-
aptic plasticity and memory formation. With this in mind,
an important aspect of these studies that should not be
overlooked is the lack of an LTP phenotype in the apoE
knockout mouse. This raises an interesting question: if
apoE is acting as a signaling molecule important for neu-
ronal function, then why is there no overt change in phys-
iology in its absence? Our results suggest a unique role for
specific apoE isoforms in the modulation of hippocampal
CA1 synaptic plasticity. In addition, both apoE isoforms
and reelin can bind to the same family of lipoprotein
receptors. The role of reelin in synaptic function and
memory formation is now well established, and specific
isoform expression can have a direct effect on reelin sign-
aling and modulation of synaptic function. Thus, apoE
isoforms may function by changing reelin's ability to
modulate NMDA receptors and activate specific signal
transduction pathways by as yet unknown mechanisms.
Furthermore, changes in apoE availability, due to spatial
changes or associations with other proteins, may have a
profound affect on synaptic function in the different sub-
fields of the hippocampus.
With renewed focus on the role of apoE in neurodegener-
ative disorders and as a potentially rich area for therapeu-
tic intervention comes the necessity to better understand
how apoE can affect synaptic function. Evolution appears
to have co-opted apoE to perform duties encompassing
far more than cholesterol transport. Acting directly
through lipoprotein receptor activation, or indirectly by
altering reelin action, apoE isoforms can have a significant
effect on NMDA receptor function. How might changes in
apoE during normal and pathological states of neurode-
generation affect synaptic plasticity and memory forma-
tion? While this question is the foundation for future
studies, our results here highlight the previously unappre-
ciated role of apoE as a modulator of hippocampus syn-
aptic plasticity.
Experimental procedures
Animal maintenance
ApoE2, apoE3 and apoE4 targeted replacement animals
were obtained from a colony maintained at Taconic
(Hudson, New York USA). ApoE-deficient and C57BL/6J
animals were obtained from Jackson Laboratories (Bar
Harbor, Maine, USA). Animals were housed in a standard
12 hour light cycle and bred and maintained in accord-
ance with the Vanderbilt University Institutional Animal
Care and Use Committee protocol.
Electrophysiology
Hippocampus slices were prepared from 3- to 5-month
old mice as previously reported [9]. The brain was rapidly
removed and placed in oxygenated ice-cold high sucrose
cutting saline solution containing (in mM) 110 sucrose,
60 NaCl, 3 KCl, 28 NaHCO3, 1.25 NaH2PO4, 5 glucose,
0.6 ascorbate, 7 MgCl2, and 0.5 CaCl2. Horizontal 400 μm
sections were cut in high sucrose cutting solution using a
vibratome. Slices were maintained in cold, oxygenated
cutting solution until dissection. After dissection, the hip-
pocampus slices were transferred to room temperature
cutting solution diluted 1:1 with artificial cerebral spinal
fluid (ACSF). ACSF contains, in mM, 125 NaCl, 2.5 KCl,
26 NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 MgCl2, and 2
CaCl2. Slices were maintained in this solution with con-
stant 95% O2/5% CO2 perfusion for 10 min before trans-
ferring to the brain slice recording chamber (Fine Science
Tools, San Francisco, California, USA).
Extracellular recording was performed using standard
techniques as previously reported [9]. The recording
chamber was maintained at 30° ± 0.5°C with a laminar
ACSF flow rate of approximately 1 mL/min. Field excita-
tory postsynaptic potentials (fEPSPs) were recorded from
area CA1 stratum radiatum via glass micropipettes pulled
to an approximate 1 μm tip diameter (1–4 MΩ) and filled
with ACSF. Responses were generated by stimulation of
fibers arising from the CA3 region. Stimulating electrodes
consisting of formvar-coated nichrome wire delivered
biphasic stimulus pulses (1–15 V, 100 μsec duration, 0.05
Hz). Delivery of stimulation, controlled by pClamp 9.0
software (Axon Instruments, Forster City, California,
USA), was via the Digidata 1322A interface (Axon Instru-
ments) and a stimulus isolator (model 2200, A-M Sys-
tems, Sequim, Washington, USA). Signals were amplified
using a differential amplifier (model 1800, A-M Systems),
filtered at 1 kHz and digitized at 10 kHz. For all experi-
ments, baseline stimulus intensity was set at the level thatMolecular Neurodegeneration 2009, 4:21 http://www.molecularneurodegeneration.com/content/4/1/21
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elicited 40–50% of the maximum fEPSP response as
determined from the input-output curve.
Long-term potentiation (LTP) was induced by theta-burst
protocol. Theta-burst LTP protocol consisted of five trains
of 10 bursts at a 5 Hz frequency with each burst consisting
of 4 stimulations delivered at 100 Hz and an inter-train
interval of 20 seconds. NMDAR-independent LTP was
induced by 2 one-second trains of stimulation delivered at
200 Hz; concurrent application of 100 μM 2-amino-5-
phosphonovaleric acid (APV) confirmed NMDAR inde-
pendence. NMDAR field potentials were isolated by incu-
bating slices on the rig in ACSF containing no Mg2+ for 15
minutes followed by addition of 20 μM 6-cyano-7-nitro-
quinoxaline-2,3-dione (CNQX) and 25 μM picrotoxin.
After 15 minutes of stabilization, slices were treated with
100 nM of recombinant human apoE isoforms (Calbio-
chem).
Statistics
Electrophysiological data was also analyzed using one-
way ANOVA with Bonferroni's post hoc tests. Significance
was set at p < 0.05 for all tests.
Biochemistry
ApoE/apoER2
Bilateral dissections of the whole hippocampus from aged
(1 year old) animals were performed. Brain tissue was rap-
idly dissected and flash frozen on dry ice. Tissue was
homogenized in NP-40 lysis buffer containing (in mM)
50 Tris-HCL ph 8.0, 150 NaCl, 1 EDTA, 1 PMSF, 1
Na3VO4, 1 NaF, 1 μg/mL each of aprotinin, leupeptin and
pepstatin, and 1% NP-40. Protein concentration was
determined by Bradford Assay (Bio-rad). For western blot
analysis, 10 μg of protein was resolved by 4–20% gradient
SDS-PAGE. The proteins were then transferred to PVDF
membranes. Membranes were probed with goat anti-
human apoE (Academy Bio-medical, Houston Texas,
USA), rabbit anti-apoER2 (a gift of Drs. Gary Olson and
Ray Burk, Vanderbilt University [40]), and rabbit anti-
actin (Sigma) diluted in 0.24% I-block. Membranes were
developed using HRP-conjugated secondary antibodies
and enhanced chemiluminescence. Optical density of
immunoreactivity was quantified by densitometry using
Image J software (NIH).
For investigations of chronic apoE exposure, slices were
obtained from apoE2 TR, apoE3 TR, apoE4 TR, apoE-defi-
cient and C57BL/6J (wild-type) mice in an identical fash-
ion as for electrophysiology (see above). The slices were
frozen on dry ice and CA1 dissected unless otherwise
stated. For investigations of acute apoE exposure, slices
were obtained from apoE-deficient mice in an identical
fashion as for electrophysiology (see above). Slices (n = 3–
4 per treatment) were incubated in ACSF at 30°C for 1
hour prior to the addition of 100 nM recombinant human
apoE2, apoE3 or apoE4 (Calbiochem) for 40 minutes.
Slices were then flash frozen on dry ice and CA1 dissected.
ERK/JNK activation
Pooled tissue was homogenized in NP-40 lysis buffer con-
taining (in mM) 50 Tris-HCL ph 8.0, 150 NaCl, 1 EDTA,
1 PMSF, 1 Na3VO4, 1 NaF, 1 μg/mL each of aprotinin, leu-
peptin and pepstatin, and 1% NP-40. Protein concentra-
tion was determined by Bradford Assay (Bio-Rad). Ten μg
of protein was resolved by SDS-PAGE on 4–15% Tris-HCL
gradient gels (Bio-Rad) and transferred to PVDF mem-
brane. Membranes were probed with rabbit anti-ERK1/2,
anti-ERK1/2 pTpY185/187, anti-JNK1/2, anti-JNK1/2
pTpY183/185 (Invitrogen) diluted in 0.24% I-block. Mem-
branes were developed using HRP-conjugated secondary
antibodies and enhanced chemiluminescence.
NMDAR subunit phosphorylation
Pooled tissue was sonicated in modified RIPA buffer (Tris/
HCl pH 7.4, 2 mM EDTA, 150 mM NaCl, 0.1% SDS, 0.5%
sodium deoxycholate, 1% triton X100, 1× phosphatase
inhibitors I and II (Sigma), and 1× complete protease
inhibitors (Sigma). Protein concentrations were deter-
mined by BCA Protein Assay (Bio-Rad). Ten μg of protein
was resolved by SDS-PAGE on 4–15% Tris-HCL gradient
gels (Bio-Rad) and transferred to PVDF membrane. Mem-
branes were probed with mouse anti-phosphotyrosine,
clone 4G10 (Millipore), rabbit anti-NR2A, rabbit anti-
NR2B (Upstate), and mouse anti-NR1 (Millipore) diluted
in 0.24% I-block. Membranes were developed using HRP-
conjugated secondary antibodies and enhanced chemilu-
minescence.
For immunoprecipitation assays, a total of 400 μg of pro-
tein lysate was used to immunoprecipitate either rabbit
anti-NR2A or rabbit anti-NR2B (Upstate) overnight at
4°C with agitation. Protein A/G magnetic beads (New
England BioLabs) were added to each reaction (25 μl bead
slurry/reaction) and samples were incubated for 2 hours
at 4°C with agitation. Following three wash cycles, the
protein was eluted with 1× Laemmli sample buffer sepa-
rated by SDS-PAGE on 4–15% Tris-HCl gradient gels (Bio-
Rad) and transferred to PVDF membranes. Membranes
were probed with mouse anti-pTyr, clone 4G10 (Milli-
pore), rabbit anti-NR2A, and rabbit anti-NR2B in 2%
BSA-TBST. Membranes were developed using HRP-conju-
gated secondary antibodies and enhanced chemilumines-
cence.
Optical density of immunoreactivity was quantified by
densitometry using Image J software (NIH).
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